Johnson & Johnson (JNJ) Lobbying Data
JNJ lobbying summary
Johnson & Johnson Services Inc (JNJ) has reported $67.2M in federal lobbying spending across 411 Senate LDA filings since 2020. Its most frequent lobbying issues are Health Issues, Taxation, Medicare/Medicaid, Budget/Appropriations. Lobbying firms used include The Washington Tax & Public Policy Group, Hart Health Strategies, Covington & Burling LLP.
Lobbying spending by year
| Year | Reported spend |
|---|---|
| 2026 | $8.0M |
| 2025 | $11.2M |
| 2024 | $10.4M |
| 2023 | $10.5M |
| 2022 | $10.4M |
| 2021 | $8.7M |
See insider trading for JNJ or the Lobbying Heavyweights strategy.
Source: Senate Lobbying Disclosure Act (LD-2) filings. The current year is partial.